Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
Saved in:
| Title: | Ranibizumab versus verteporfin for neovascular age-related macular degeneration. |
|---|---|
| Authors: | Brown DM (AUTHOR), Kaiser PK (AUTHOR), Michels M (AUTHOR), Soubrane G (AUTHOR), Heier JS (AUTHOR), Kim RY (AUTHOR), Sy JP (AUTHOR), Schneider S (AUTHOR), ANCHOR Study Group (CORPORATE AUTHOR), Brown, David M1 (AUTHOR), Kaiser, Peter K (AUTHOR), Michels, Mark (AUTHOR), Soubrane, Gisele (AUTHOR), Heier, Jeffrey S (AUTHOR), Kim, Robert Y (AUTHOR), Sy, Judy P (AUTHOR), Schneider, Susan (AUTHOR) |
| Source: | New England Journal of Medicine. 10/5/2006, Vol. 355 Issue 14, p1432-1444. 13p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
